Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
Counterterrorism: creating a safe, stable, easily stored anthrax vaccine A vaccine candidate for anthrax infection shows promise for improving preparedness for a biological attack. Bacillus anthracis, the bacterium responsible for anthrax is a top-tier bioterrorism agent due to its high lethality an...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6ed55cb74e9406db34a5f3fb0bf3838 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e6ed55cb74e9406db34a5f3fb0bf3838 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e6ed55cb74e9406db34a5f3fb0bf38382021-12-02T16:20:00ZProtection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis10.1038/s41541-017-0018-42059-0105https://doaj.org/article/e6ed55cb74e9406db34a5f3fb0bf38382017-06-01T00:00:00Zhttps://doi.org/10.1038/s41541-017-0018-4https://doaj.org/toc/2059-0105Counterterrorism: creating a safe, stable, easily stored anthrax vaccine A vaccine candidate for anthrax infection shows promise for improving preparedness for a biological attack. Bacillus anthracis, the bacterium responsible for anthrax is a top-tier bioterrorism agent due to its high lethality and spore stability. The current FDA-approved anthrax vaccine and other vaccine candidates in development lack ease of preparation, have short shelf lives and adverse effects. B. Kim Lee Sim of Protein Potential LLC and her collaborators combined key B. anthracis genetic material into an existing typhoid vaccine. The vaccine vector possesses high stability, a strong safety record, and offers long-term protection after oral administration, which Sim’s group hopes to preserve in their candidate anthrax vaccine. The team showed that their hybrid vaccine conferred excellent protection in rabbits and a short vaccination regimen, and suggest further studies into its suitability for human vaccine studies.B. Kim Lee SimMinglin LiManuel OsorioYun WuTint T. WaiJohnny W. PetersonEric R. JamesSumana ChakravartyLixin GaoRui XuNatasha KCRichard E. StaffordWilliam S. LawrenceLinsey A. YeagerJennifer E. PeelSatheesh K. SivasubramaniAshok K. ChopraSvetlana FilippovaStephen L. HoffmanNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 2, Iss 1, Pp 1-7 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 B. Kim Lee Sim Minglin Li Manuel Osorio Yun Wu Tint T. Wai Johnny W. Peterson Eric R. James Sumana Chakravarty Lixin Gao Rui Xu Natasha KC Richard E. Stafford William S. Lawrence Linsey A. Yeager Jennifer E. Peel Satheesh K. Sivasubramani Ashok K. Chopra Svetlana Filippova Stephen L. Hoffman Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis |
description |
Counterterrorism: creating a safe, stable, easily stored anthrax vaccine A vaccine candidate for anthrax infection shows promise for improving preparedness for a biological attack. Bacillus anthracis, the bacterium responsible for anthrax is a top-tier bioterrorism agent due to its high lethality and spore stability. The current FDA-approved anthrax vaccine and other vaccine candidates in development lack ease of preparation, have short shelf lives and adverse effects. B. Kim Lee Sim of Protein Potential LLC and her collaborators combined key B. anthracis genetic material into an existing typhoid vaccine. The vaccine vector possesses high stability, a strong safety record, and offers long-term protection after oral administration, which Sim’s group hopes to preserve in their candidate anthrax vaccine. The team showed that their hybrid vaccine conferred excellent protection in rabbits and a short vaccination regimen, and suggest further studies into its suitability for human vaccine studies. |
format |
article |
author |
B. Kim Lee Sim Minglin Li Manuel Osorio Yun Wu Tint T. Wai Johnny W. Peterson Eric R. James Sumana Chakravarty Lixin Gao Rui Xu Natasha KC Richard E. Stafford William S. Lawrence Linsey A. Yeager Jennifer E. Peel Satheesh K. Sivasubramani Ashok K. Chopra Svetlana Filippova Stephen L. Hoffman |
author_facet |
B. Kim Lee Sim Minglin Li Manuel Osorio Yun Wu Tint T. Wai Johnny W. Peterson Eric R. James Sumana Chakravarty Lixin Gao Rui Xu Natasha KC Richard E. Stafford William S. Lawrence Linsey A. Yeager Jennifer E. Peel Satheesh K. Sivasubramani Ashok K. Chopra Svetlana Filippova Stephen L. Hoffman |
author_sort |
B. Kim Lee Sim |
title |
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis |
title_short |
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis |
title_full |
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis |
title_fullStr |
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis |
title_full_unstemmed |
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis |
title_sort |
protection against inhalation anthrax by immunization with salmonella enterica serovar typhi ty21a stably producing protective antigen of bacillus anthracis |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/e6ed55cb74e9406db34a5f3fb0bf3838 |
work_keys_str_mv |
AT bkimleesim protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT minglinli protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT manuelosorio protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT yunwu protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT tinttwai protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT johnnywpeterson protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT ericrjames protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT sumanachakravarty protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT lixingao protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT ruixu protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT natashakc protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT richardestafford protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT williamslawrence protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT linseyayeager protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT jenniferepeel protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT satheeshksivasubramani protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT ashokkchopra protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT svetlanafilippova protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis AT stephenlhoffman protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis |
_version_ |
1718384205431308288 |